100% tevredenheidsgarantie Direct beschikbaar na betaling Zowel online als in PDF Je zit nergens aan vast
logo-home
NSG 533 EXAM 1 (LATEST 2024 / 2025): ADVANCED PHARMACOLOGY QUESTIONS & ANSWERS WITH RATIONALES COMPLETE AND WELL EXPLAINED BY EXPERTS ALREADY PASSED 100% CORRECT GRADED A+ LATEST UPDATE 2024 100% GUARANTEED SUCCESS AFTER DOWNLOAD (ALL YOU NEED TO PASS YOU €7,30   In winkelwagen

Tentamen (uitwerkingen)

NSG 533 EXAM 1 (LATEST 2024 / 2025): ADVANCED PHARMACOLOGY QUESTIONS & ANSWERS WITH RATIONALES COMPLETE AND WELL EXPLAINED BY EXPERTS ALREADY PASSED 100% CORRECT GRADED A+ LATEST UPDATE 2024 100% GUARANTEED SUCCESS AFTER DOWNLOAD (ALL YOU NEED TO PASS YOU

 8 keer bekeken  0 keer verkocht
  • Vak
  • NSG 533
  • Instelling
  • NSG 533
  • Boek

NSG 533 EXAM 1 (LATEST 2024 / 2025): ADVANCED PHARMACOLOGY QUESTIONS & ANSWERS WITH RATIONALES COMPLETE AND WELL EXPLAINED BY EXPERTS ALREADY PASSED 100% CORRECT GRADED A+ LATEST UPDATE 2024 100% GUARANTEED SUCCESS AFTER DOWNLOAD (ALL YOU NEED TO PASS YOUR EXAMS) EP is a 38-year-old female patie...

[Meer zien]

Voorbeeld 3 van de 24  pagina's

  • 24 augustus 2024
  • 24
  • 2024/2025
  • Tentamen (uitwerkingen)
  • Vragen en antwoorden
  • NSG 533
  • NSG 533
avatar-seller
NSG 533 EXAM 1 (LATEST 2024
/ 2025): ADVANCED
PHARMACOLOGY QUESTIONS
& ANSWERS WITH
RATIONALES COMPLETE AND
WELL EXPLAINED BY EXPERTS
ALREADY PASSED 100%
CORRECT GRADED A+ LATEST
UPDATE 2024 100%
GUARANTEED SUCCESS AFTER
DOWNLOAD (ALL YOU NEED
TO PASS YOUR EXAMS)

,
, Despite improvements in the past six weeks due to lifestyle changes and exercise, drug therapy is to be
started for JR's diabet Metformin is the drug of choice recommended for most patients with diabetes
in addition to lifestyle modifications assuming no contraindications or intolerabilities are present upon
evaluation. Metformin has also shown to provide positive weight neutral/loss effects in obese patients.
It is crucial to know the renal status of patients commencing metformin therapy to limit the risk of lactic
acidosis (JR is without contraindication).

Since his entry A1C is >7.5%, dual therapy is indicated. There are several potential choices. The second
step can be a dipeptidyl peptidase-4 inhibitor, it can be a glucagon-like peptide-1 (GLP-1) receptor
agonist, it can be a TZD, it can be a sulfonylurea agent, it can be a SGLT2 inhibitor, or it could be basal
insulin. Anything next can be tried depending on what suits the circumstance

DPP4 inhibitors are weight neutral bet relatively benign side effect profile. Sitagliptin has been
associated with case reports of pancreatitis, so this specific agent should be avoided. $$$

GLP-1 analog and has data to support an A1C reduction necessary to gain glycemic control and may
assist with weight loss goals for this patient. New information suggests these agents may provide
benefits in those with ASCVD. JR has a past history of pancreatitis and GLP-1 analogs are not
recommended due to this contraindication

TZDs have data to support an A1C reduction necessary to gain glycemic control, but are associated with
weight gain, negative effects on lipids and increased risk of fracture. Until recently, TZDs have also been
linked to increased CV events and use has fallen out of favor

Sulfonylureas provide excellent A1C lowering, but are also associated with weight gain. They also have
the potential to cause hypoglycemia, so patient education is crucial. Because of his allergies to "sulfa",
use would be contr

A patient with type 1 diabetes reports taking propranolol for hypertension. What concern does this
information present for the provider? A patient with Type 1 DM is insulin dependent for glucose
control and at high risk for hypoglycemic episodes. Propanolol causes prolonged hypoglycemic episodes.
Needs to switch to ACE or ARB.

EP is a 38-year-old female patient that comes in for diabetes education and management. She was
diagnosed 12 years ago and states lately she is not able to control her diet although she continues a
1600 calorie diet with appropriate daily carbohydrate intake (per dietitian prescription) and walks 40
minutes every day of the week. She states compliance with all medications. She denies any history of
hypoglycemia despite being able to identify signs and symptoms and describe appropriate treatment
strategies.

PMH: T2DM, HTN, obesity, depression, s/p thyroidectomy due to thyroid cancer

FmHx: Noncontributory

SHx: (−) Smoking, alcohol use, past marijuana use while in high school

Medications: Metformin 850 mg tid, glipizide 20 mg bid, lisinopril 20 mg daily, sertraline 100 mg daily,
multivitamin daily

Vitals: BP 128/82 mg Hg; P 72 beats/min; BMI 31 m/kg2

Voordelen van het kopen van samenvattingen bij Stuvia op een rij:

Verzekerd van kwaliteit door reviews

Verzekerd van kwaliteit door reviews

Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!

Snel en makkelijk kopen

Snel en makkelijk kopen

Je betaalt supersnel en eenmalig met iDeal, creditcard of Stuvia-tegoed voor de samenvatting. Zonder lidmaatschap.

Focus op de essentie

Focus op de essentie

Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!

Veelgestelde vragen

Wat krijg ik als ik dit document koop?

Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.

Tevredenheidsgarantie: hoe werkt dat?

Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.

Van wie koop ik deze samenvatting?

Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper ESCALITothethinker. Stuvia faciliteert de betaling aan de verkoper.

Zit ik meteen vast aan een abonnement?

Nee, je koopt alleen deze samenvatting voor €7,30. Je zit daarna nergens aan vast.

Is Stuvia te vertrouwen?

4,6 sterren op Google & Trustpilot (+1000 reviews)

Afgelopen 30 dagen zijn er 78140 samenvattingen verkocht

Opgericht in 2010, al 14 jaar dé plek om samenvattingen te kopen

Start met verkopen
€7,30
  • (0)
  Kopen